| Restated | |||
Notes | 01.01.2024 | 01.01.2023 | |
| In thousands of EUR | 31.12.2024 | 31.12.2023 | |
| Net income from financial assets at fair value through profit or loss | |||
| Private equity | |||
| Interest & dividend income | 9 | ||
| Revaluation | 9 | ||
| Withholding tax on direct private equity investments | 9 | ( | ( |
| Net foreign exchange gains / (losses) | ( | ||
| Other assets | ( | ||
| Interest & dividend income | 9 | ( | |
| Revaluation | 9 | ( | |
| Withholding tax on other assets | 9 | ( | |
| Net foreign exchange gains / (losses) | ( | ||
| Net income from cash & cash equivalents and other income | ( | ( | |
| Interest & dividend income | |||
| Withholding tax on interest income | ( | ||
| Net foreign exchange gains / (losses) | ( | ( | |
| Total net income | |||
| Operating expenses | ( | ( | |
Management fees | 19 | ( | ( |
Incentive fees | 15,19 | ( | ( |
Administration fees | 19 | ( | ( |
Service fees | 19 | ( | ( |
| Other operating expenses | ( | ( | |
| Revaluation of other long-term receivables | ( | ||
| Other net foreign exchange gains / (losses) | ( | ( | |
| Other financial activities | ( | ||
| Interest expense - credit facilities | 14 | ( | ( |
| Other finance cost | ( | ( | |
| Net gains / (losses) from hedging activities | 11 | ||
| Other income | |||
| Surplus / (loss) for period before tax | |||
| Income tax expense | ( | ( | |
| Other comprehensive income for period; net of tax |
| Restated | |||
Notes | 01.01.2024 | 01.01.2023 | |
| In thousands of EUR | 31.12.2024 | 31.12.2023 | |
| Surplus / (loss) for period after tax | |||
Total comprehensive income for period | |||
Weighted average number of shares outstanding | |||
Basic surplus / (loss) per share for period (in EUR) | |||
< < < D i > > > luted surplus / (loss) per share for period (in EUR) |
| Restated | |||
| Notes | 31.12.2024 | 31.12.2023 | |
| In thousands of EUR | |||
| ASSETS | |||
| Financial assets at fair value through profit or loss | |||
| Private equity | 9, 18 | ||
9, 18 | |||
| Other assets | |||
| Other long-term receivables | |||
| Non-current assets | |||
Other short-term receivables | 18 | ||
| Cash and cash equivalents | |||
| Withheld taxes available for deemed distributions | |||
| Current assets | |||
| TOTAL ASSETS | |||
| EQUITY AND LIABILITIES | |||
Share capital | 12 | ||
| Reserves | |||
| Total equity | |||
| Short-term credit facilities | 14 | ||
| Accruals and other short-term payables | 10 | ||
| Liabilities falling due within one year | |||
| TOTAL EQUITY AND LIABILITIES |
Share capital | Reserves | Total | |
| In thousands of EUR | |||
Balance at the beginning of period | |||
Dividends paid | ( | ( | |
Surplus / (loss) for period after tax | |||
Equity at end of period |
Share capital | Reserves | Total | |
In thousands of EUR | |||
Balance at the beginning of period | |||
Dividends paid | ( | ( | |
Surplus / (loss) for period after tax | |||
Equity at end of period |
| Restated | ||||
| Notes | 01.01.2024 | 01.01.2023 | ||
| In thousands of EUR | 31.12.2024 | 31.12.2023 | ||
| Operating activities | ||||
| Surplus / (loss) for period before interest expense | ||||
| Adjustments: | ||||
| Net foreign exchange (gains) / losses | ( | |||
| Investment revaluation | ( | ( | ||
| Withholding tax on direct investments | ||||
| Revaluation of other long-term receivables | ||||
| Net result from interest income / (expense) | ( | |||
| Net result from dividend income | ( | ( | ||
| Revaluation on forward hedges | 11 | ( | ||
| (Increase) / decrease in receivables | ( | |||
| (Increase) / decrease in withheld taxes available for deemed distributions | ( | |||
| Increase / (decrease) in payables | ( | |||
| Realized gains / (losses) from forward hedges | 11 | |||
| Purchase of private equity investments | 9 | ( | ( | |
| Purchase of other investments | 9 | ( | ( | |
| Distributions from and proceeds from sales of private equity investments | 9 | |||
| Distributions from other investments | 9 | |||
| Interest & dividends received | ||||
| Net cash from / (used in) operating activities | ||||
| Financing activities | ||||
Increase in credit facilities | 14 | |||
(Decrease) in credit facilities | 14 | ( | ( | |
Interest paid | - credit facilities | 14 | ( | ( |
Dividends paid | 12 | ( | ( | |
| Net cash from / (used in) financing activities | ( | ( | ||
| Net increase / (decrease) in cash and cash equivalents | ( | |||
| Cash and cash equivalents at beginning of period | ||||
| Effects of foreign currency exchange rate changes on cash and cash equivalents | ( | ( | ||
| Cash and cash equivalents at end of period |
| Restated | ||
01.01.2024 | 01.01.2023 | |
| In thousands of EUR | 31.12.2024 | 31.12.2023 |
| Private equity | ||
Interest & dividend income | 10,474 | 47 |
Revaluation | 128,843 | 54,660 |
Withholding tax on direct private equity investments | (2,281) | (832) |
Net foreign exchange gains / (losses) | 27,200 | (10,253) |
Total net income private equity | 164,236 | 43,622 |
Segment result private equity | 164,236 | 43,622 |
| Other Assets | ||
Interest & dividend income | - | (183) |
Revaluation | (11,664) | 4,382 |
Withholding tax on other assets | (110) | - |
Net foreign exchange gains / (losses) | 1,867 | (1,576) |
Total net income other assets | (9,907) | 2,623 |
| Non-attributable | ||
Interest & dividend income | 64 | - |
Net foreign exchange gains / (losses) | (180) | (17) |
Total net income non-attributable | (116) | (17) |
Segment result non-attributable (including total net income non-attributable) | (42,840) | (28,963) |
Other financial activities not allocated | (2,309) | 1,142 |
Surplus / (loss) for the financial period before tax | 109,180 | 18,424 |
Income tax expense | (260) | (3) |
Surplus / (loss) for the financial period after tax | 108,920 | 18,421 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Balance at beginning of period | 969,391 | 968,814 |
Purchase of Direct and Indirect Investments | 33,094 | 4,790 |
Distributions from and proceeds from sales of Direct and Indirect Investments | (127,288) | (47,799) |
Reclassification of investments | 21,095 | - |
Accrued cash and PIK interest | (11) | 11 |
Revaluation | 128,843 | 54,660 |
Withholding tax on direct private equity investments | (2,281) | (832) |
Net foreign exchange gains / (losses) | 27,200 | (10,253) |
Balance at end of period | 1,050,043 | 969,391 |
Movement in unrealized gains / (losses) still held at end of period | 50,565 | 20,460 |
| Restated | ||
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Balance at beginning of period | 59,668 | 61,257 |
Purchase of Direct and Indirect Investments | 1 | 984 |
Distributions from and proceeds from sales of Direct and Indirect Investments | (3,660) | (4,718) |
Reclassification of investments | (21,095) | - |
Accrued cash and PIK interest | - | (661) |
Revaluation | (11,664) | 4,382 |
Withholding tax on other assets | (110) | - |
Net foreign exchange gains / (losses) | 1,867 | (1,576) |
Balance at end of period | 25,007 | 59,668 |
Movement in unrealized gains / (losses) still held at end of period | (4,210) | 5,395 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Unfunded commitments translated at the rate prevailing at end of period | 120,579 | 115,294 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
| Issued and fully paid | ||
69,151,168 ordinary shares of EUR 0.001 each out of the bond conversion | 69 | 69 |
Total issued and fully paid shares | 69 | 69 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
| Short-term credit facility | ||
Balance at beginning of period | 19,000 | - |
Increase in credit facility | 55,000 | 49,200 |
(Decrease) in credit facility | (74,000) | (30,200) |
Balance at end of period | - | 19,000 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
| Balance at beginning of period | 37,733 | 28,831 |
Change in incentive fees attributable to Investment Manager | 25,051 | 11,027 |
Incentive fees paid/payable | (12,469) | (2,125) |
Balance at end of period | 50,315 | 37,733 |
Incentive fees accrued | 84,479 | 69,352 |
Incentive fee rebates accrued | (34,164) | (31,619) |
Total net incentive fees | 50,315 | 37,733 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Net asset value of the Group | 1,039,068 | 979,245 |
Outstanding shares at the end of the reporting period | 69,151,168.00 | 69,151,168.00 |
Net asset value per share at period end (in EUR) | 15.03 | 14.16 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Net assets denominated in AUD | 1 | 1 |
Net assets denominated in CHF | 52,824 | 52,556 |
Net assets denominated in GBP | 24,709 | 38,634 |
Net assets denominated in USD | 416,803 | 430,879 |
Net assets denominated in INR | 46,841 | 25,179 |
Net assets denominated in ILS | 1 | 1 |
Applicable annual volatility AUD | 7.88% | 7.85% |
Applicable annual volatility CHF | 6.45% | 6.31% |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Applicable annual volatility GBP | 6.48% | 6.55% |
Applicable annual volatility USD | 7.43% | 7.51% |
Applicable annual volatility INR | 7.69% | 7.85% |
Applicable annual volatility ILS | 8.15% | 7.97% |
Fluctuation of net assets and corresponding results depending on above-mentioned volatility | 39,579 | 40,183 |
| 31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
| Mezzanine and senior debt investments | 19 | 295 |
Cash and cash equivalents | 18,651 | 9,744 |
Credit facility | - | (19,000) |
Total variable rate instruments | 18,670 | (8,961) |
100bp increase | 100bp | |
| In thousands of EUR | decrease | |
| Impact on variable rate instruments | 187 | (187) |
| 100bp increase | 100bp | |
| In thousands of EUR | decrease | |
Impact on variable rate instruments | (90) | 90 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Too early | - | - |
With issues | 19 | 295 |
On plan | - | - |
Above plan | - | - |
Outperformer | - | - |
Total | 19 | 295 |
Not past due | Past due less | Past due more | |
| In thousands of EUR | than 1 year | than 1 year | |
Cash and cash equivalents | 18,651 | - | - |
Other short-term receivables | 1,153 | - | - |
Other long-term receivables | 54 | - | - |
Mezzanine and senior debt investments | 19 | - | - |
| Not past due | Past due less | Past due more | |
In thousands of EUR | than 1 year | than 1 year | |
Cash and cash equivalents | 9,744 | - | - |
Other short-term receivables | 4,245 | - | - |
Other long-term receivables | 1,383 | - | - |
Mezzanine and senior debt investments | 295 | - | - |
Less than 3 | 3 to 12 months | More than 12 | |
| In thousands of EUR | months | months | |
Unfunded commitments to Direct and Indirect Investments | (120,579) | - | - |
Liabilities falling due within one year | (5,525) | (50,315) | - |
Current assets | 19,804 | - | - |
Other long-term receivables | - | - | 54 |
Undrawn credit facility | 140,000 | - | - |
Total | 33,700 | (50,315) | 54 |
| Less than 3 | 3 to 12 months | More than 12 | |
In thousands of EUR | months | months | |
Unfunded commitments to Direct and Indirect Investments | (115,294) | - | - |
Liabilities falling due within one year | (27,858) | (37,733) | - |
Current assets | 14,394 | - | - |
Other long-term receivables | - | - | 1,383 |
Undrawn credit facility | 121,000 | - | - |
Total | (7,758) | (37,733) | 1,383 |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Financial assets at fair value through profit or loss | 1,075,050 | 1,029,059 |
Total assets subject to market risk | 1,075,050 | 1,029,059 |
Annual expected volatility | 14.12% | 14.08% |
Potential impact on audited consolidated financial statements | 151,797 | 144,892 |
| 31.12.2024 | |
| NAV in thousands of EUR | |
| Region & Strategy | |
| North America | |
Buyout | 292,096 |
| Other strategies | 7,655 |
| Western Europe | |
Buyout | 272,623 |
| Other strategies | 28,568 |
| Rest of World | |
Buyout | 1,943 |
Other strategies | 2,505 |
| 31.12.2023 | |
NAV in thousands of EUR | |
| Region & Strategy | |
| North America | |
| Buyout | 216,947 |
| Other strategies | 13,265 |
| Western Europe | |
Buyout | 158,037 |
| Other strategies | 22,908 |
| Rest of World | |
Buyout | 2,042 |
Other strategies | 4,848 |
Level 1 | Level 2 | Level 3 | Total balance | |
| In thousands of EUR | ||||
| Assets | ||||
| Other short-term receivables | - | - | 1,153 | 1,153 |
| Financial assets at fair value through profit or loss - equity | - | - | 1,067,600 | 1,067,600 |
| securities | ||||
| Financial assets at fair value through profit or loss - debt | - | - | 7,450 | 7,450 |
| investments | ||||
| Total assets | - | - | 1,076,203 | 1,076,203 |
| Liabilities | ||||
| Total liabilities | - | - | - | - |
| Level 1 | Level 2 | Level 3 | Total balance | |
| In thousands of EUR | ||||
Assets | ||||
Other short-term receivables | - | - | 4,245 | 4,245 |
| Financial assets at fair value through profit or loss - equity | - | - | 1,008,436 | 1,008,436 |
| securities | ||||
Financial assets at fair value through profit or loss - debt | - | - | 20,623 | 20,623 |
| investments | ||||
Total assets | - | - | 1,033,304 | 1,033,304 |
| Liabilities | ||||
Total liabilities | - | - | - | - |
| Type of | Fair value at | Valuation | Significant | Range | Sensitivity | |
| security | 31.12.2024 | technique | Unobservable | (weighted | ||
| input | average) | |||||
| Fair value in thousands of EUR | ||||||
| Equity | 863,104 | Market | Enterprise value | 7.70x - 33.10x | 68,809 | (68,809) |
| Instruments | comparable | to EBITDA | (17.33x) | |||
| multiple | ||||||
| companies | ||||||
| 39,637 | Exit price | Recent | n.a. | n.a. | n.a. | |
| transaction price | ||||||
29,001 | Discounted | Discount factor | 12.90% - 15.30% | 696 | (696) | |
| cash flow | (14.00%) | |||||
21,101 | Market | Price to book | 1.92x - 1.92x | 1'055 | (1,055) | |
| comparable | ratio | (1.92x) | ||||
| companies | ||||||
| 15,416 | Market | Enterprise value | 2.00x - 16.50x | 755 | (755) | |
| comparable | ||||||
companies | to sales multiple | (5.46x) | ||||
| 2,555 | Recent | Recent | n.a. | n.a. | n.a. | |
| financing/ | transaction price | |||||
| transaction | ||||||
| 374 | Reported fair | Reported fair | n.a | 19 | (19) | |
value | value | |||||
Debt | 2,173 | Market | Enterprise value | 7.25x - 7.50x | n.a. | n.a. |
| Instruments | comparable | to EBITDA | (7.43x) | |||
| companies | ||||||
| 640 | Discounted | Discount factor | 15.00% - 15.00% | 5 | (5) | |
| cash flow | ||||||
| (15.00%) | ||||||
| 26 | Exit price | Recent | n.a. | n.a. | n.a. | |
| transaction price | ||||||
| Partnership | 6,980 | Adjusted | Reported net | n.a. | 349 | (349) |
| Investments | reported net | asset value | ||||
| asset value | ||||||
| 360 | Adjusted | Fair value | n.a. | 18 | (18) | |
| reported net | adjustments | |||||
| asset value | ||||||
981,368 | Total | |||||
| 93,682 | Amounts from Partners Group investment vehicles | |||||
1,075,050 | Total level 3 investments | |||||
| Type of | Fair value at | Valuation | Significant | Range | Sensitivity | |
| security | 31.12.2024 | technique | Unobservable | (weighted | ||
| input | average) | |||||
| Fair value in thousands of EUR | ||||||
Equity | 948,459 | Market | Enterprise value | 7.50x- 35.20x | 78,095 | (78,095) |
| Instruments | comparable | to EBITDA | (16.88x) | |||
companies | multiple | |||||
41,685 | Discounted | Discount factor | 14.00% - 16.75% | 1,312 | (1,312) | |
cash flow | (14.55%) | |||||
25,046 | Exit price | Recent | n.a. | n.a. | n.a. | |
transaction price | ||||||
| 15,811 | Market | Price to book | 1.90x - 1.90x | 791 | (791) | |
| comparable | ratio | (1.90x) | ||||
companies | ||||||
| 12,212 | Market | Enterprise value | 2.10x- 20.40x | 761 | (761) | |
| comparable | to sales multiple | (6.81x) | ||||
| companies | ||||||
| 419 | Reported | Reported fair | n.a | 21 | (21) | |
| fair value | value | |||||
| Debt | 4,836 | Discounted | Discount factor | 12.00% - 20.00% | 55 | (55) |
Instruments | cash flow | (16.03%) | ||||
| 1,292 | Market | Enterprise value | 11.00x - 11.00x | n.a. | n.a. | |
| comparable | to EBITDA | (11.00x) | ||||
| companies | multiple | |||||
| 320 | Market | Enterprise value | 2.80x - 2.80x | n.a. | n.a. | |
| comparable | to sales multiple | (2.80x) | ||||
| companies | ||||||
| 81 | Exit price | Recent | n.a. | n.a. | n.a. | |
| transaction price | ||||||
| Partnership | 10,333 | Adjusted | Reported net | n.a. | 517 | (517) |
| Investments | reported net | asset value | ||||
| asset value | ||||||
| Adjusted | Fair value | n.a. | 23 | (23) | ||
| 454 | ||||||
| reported net | adjustments | |||||
| asset value | ||||||
1,060,948 | Total | |||||
| (31,889) | Amounts from Partners Group investment vehicles | |||||
1,029,059 | Total level 3 investments | |||||
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Management fee expenses | 14,744 | 15,535 |
Partners Group AG | 14,744 | 15,535 |
Administration fee expenses | 469 | 474 |
Partners Group (Guernsey) Limited | 469 | 474 |
Service fee expenses | 250 | 292 |
Partners Group AG | 250 | 292 |
Incentive fee expenses | 25,051 | 11,027 |
Partners Group AG | 25,051 | 11,027 |
Incentive fee paid | (12,469) | (2,125) |
Partners Group AG | (12,469) | (2,125) |
Directors' fee expenses | 370 | 280 |
| Invested amounts and distributions from / (to) Partners Group advised products (investment | 22,971 | 37,007 |
| side), net |
31.12.2024 | 31.12.2023 | |
| In thousands of EUR | ||
Other short-term receivables | 1,053 | 873 |
Partners Group affiliated entities | 1,053 | 872 |
Receivable from Investments | - | 1 |
Accruals and other short-term payables | (4,367) | (6,364) |
Partners Group affiliated entities | (4,367) | (6,270) |
Payable to Investments | - | (94) |
Accrued incentive fee | (50,315) | (37,733) |
Partners Group AG | (50,315) | (37,733) |
Investments in Partners Group advised products | 947,217 | 941,632 |
Fair value of investments advised by Partners Group or related parties | 781,756 | 696,669 |